Skip to content

Outset Medical Privacy Notice

Updated: June 30, 2024

Outset Medical (“Outset,” “We,” “Us,” “Our,” “the Company”) respects the privacy of your personal information.

DISCLAIMERS:

*The Tablo® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.
2214-v1
Stay connected
© 2024 Outset Medical, Inc. All rights reserved. Outset, Tablo, TabloCart, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.